Case Report: Co-infection with SARS-CoV-2 and influenza H1N1 in a patient with acute respiratory distress syndrome .
Lekbir BaalaDalila Benzekri-LefevreLaurent BretClémence GuillaumeLaura CourtellemontAbdelkrim El KhalilThomas GuerySophie IquelOlivier PercheKhalid KhadreThomas BrungsJulien DeckerThomas FranciaJulie BoisBenoit DelamareJérôme GuinardLaurence GotSylvain BriaultThierry BoulainEric LegacPublished in: F1000Research (2020)
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and has been a global public health concern. Co-infection of SARS-CoV-2 and other respiratory syndrome has been rarely reported. We report coinfection of SARS-CoV-2 and 2009 H1N1 Influenza strain in a French patient with pneumonia leading to acute respiratory distress syndrome . The patient also had a medical history of pulmonary sarcoidosis with a restrictive ventilatory syndrome, which would be a supplementary risk to develop a poor outcomes. This case highlights the possible coinfection of two severe SARS-CoV-2 and influenza H1N1 viruses, which presents a higher risk to extend the care duration. The overlapping clinical features of the two respiratory syndromes is a challenge, and awareness is required to recommend an early differential diagnosis.
Keyphrases
- sars cov
- respiratory syndrome coronavirus
- acute respiratory distress syndrome
- case report
- coronavirus disease
- extracorporeal membrane oxygenation
- mechanical ventilation
- public health
- healthcare
- palliative care
- pulmonary hypertension
- intensive care unit
- pain management
- respiratory failure
- early onset
- metabolic syndrome
- quality improvement
- health insurance